TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $26,000 | -98.2% | 53,121 | -95.2% | 0.00% | – |
| Q1 2019 | $1,469,000 | +3.7% | 1,095,945 | -12.6% | 0.00% | – |
| Q4 2018 | $1,417,000 | -57.3% | 1,254,377 | +4.2% | 0.00% | – |
| Q3 2018 | $3,322,000 | -19.4% | 1,203,672 | +4.2% | 0.00% | – |
| Q2 2018 | $4,124,000 | +19.1% | 1,155,590 | +2.4% | 0.00% | – |
| Q1 2018 | $3,464,000 | -42.6% | 1,128,581 | +17.8% | 0.00% | – |
| Q4 2017 | $6,034,000 | -5.1% | 957,890 | +3.0% | 0.00% | -100.0% |
| Q3 2017 | $6,361,000 | +23.2% | 930,274 | +28.3% | 0.00% | – |
| Q2 2017 | $5,165,000 | -17.6% | 725,094 | +6.4% | 0.00% | -100.0% |
| Q1 2017 | $6,265,000 | +118.8% | 681,533 | -4.1% | 0.00% | – |
| Q4 2016 | $2,864,000 | +6.9% | 710,982 | +1.6% | 0.00% | – |
| Q3 2016 | $2,679,000 | -10.4% | 699,591 | +0.6% | 0.00% | – |
| Q2 2016 | $2,989,000 | -6.8% | 695,480 | +0.5% | 0.00% | – |
| Q1 2016 | $3,206,000 | -76.6% | 691,905 | -49.5% | 0.00% | -100.0% |
| Q4 2015 | $13,729,000 | -49.7% | 1,369,560 | -62.6% | 0.00% | -33.3% |
| Q3 2015 | $27,319,000 | -57.7% | 3,662,875 | +169.4% | 0.00% | -57.1% |
| Q2 2015 | $64,523,000 | +23.5% | 1,359,796 | -4.6% | 0.01% | +40.0% |
| Q1 2015 | $52,233,000 | +8.3% | 1,425,547 | +17.3% | 0.01% | 0.0% |
| Q4 2014 | $48,244,000 | +796.4% | 1,214,921 | +350.5% | 0.01% | +400.0% |
| Q3 2014 | $5,382,000 | +64.4% | 269,689 | +11.2% | 0.00% | – |
| Q2 2014 | $3,273,000 | +89.6% | 242,604 | +53.1% | 0.00% | – |
| Q1 2014 | $1,726,000 | +9.9% | 158,484 | +36.3% | 0.00% | – |
| Q4 2013 | $1,571,000 | +90.7% | 116,258 | +61.0% | 0.00% | – |
| Q3 2013 | $824,000 | +402.4% | 72,212 | +211.3% | 0.00% | – |
| Q2 2013 | $164,000 | – | 23,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |